Marché du cancer colorectal en Amérique du Nord jusqu’en 2027 – Analyse régionale et prévisions par modalité (type de diagnostic, type de thérapie, type d’imagerie) ; Utilisateur final (hôpitaux, laboratoires de diagnostic et de recherche) et pays
Le marché du cancer colorectal en Amérique du Nord devrait passer de 8 559,27millions de dollars américains en 2022 à 11 198,11 millions de dollars américains d’ici 2028 ; on estime qu\'il augmentera à un TCAC de 3,4 % entre 2022 et 2028.
Le cancer colorectal est l\'un des plus graves on trouve couramment des cancers mortels chez les individus sous l’influence combinée de facteurs génétiques et environnementaux. Une population importante en Amérique du Nord reçoit un diagnostic de cancer colorectal. Selon les Centers for Disease Control and Prevention (CDC) et l\'American Cancer Society, environ 1,93 millions d\'adultes aux États-Unis ont reçu un diagnostic de cancer du côlon et du rectum, et 53 200 décès ont été causés par le cancer colorectal en 2020. Ces statistiques montrent une demande accrue. pour les diagnostics et les traitements avancés du cancer dans la région. Ainsi, la prévalence croissante du cancer colorectal et le nombre croissant de patients diagnostiqués avec la maladie stimulent la croissance du marché du cancer colorectal en Amérique du Nord.
Grâce aux nouvelles fonctionnalités et technologies, les fournisseurs peuvent attirer de nouveaux clients et étendre leur présence sur les marchés émergents. Ce facteur est susceptible de conduire le marché du cancer colorectal en Amérique du Nord à un TCAC substantiel au cours de la période de prévision.
Cancer colorectal en Amérique du Nord
Chiffre d\'affaires et prévisions du marché jusqu\'en 2028 (millions de dollars américains)
Segmentation du marché du cancer colorectal en Amérique du Nord
Le marché du cancer colorectal en Amérique du Nord est segmenté en modalité, utilisateur final et pays. Sur la base des modalités, le marché nord-américain du cancer colorectal est segmenté en type de diagnostic, type de thérapie et type d’imagerie. En 2022, le segment des types de diagnostic détenait la plus grande part de marché et devrait enregistrer le TCAC le plus élevé au cours de la période de prévision. Basé sur l’utilisateur final, le marché nord-américain du cancer colorectal est divisé en hôpitaux et services de diagnostic et de diagnostic. laboratoires de recherche. En 2022, le segment des hôpitaux détenait une part de marché plus importante. En fonction des pays, le marché nord-américain du cancer colorectal est segmenté entre les États-Unis, le Canada et le Mexique. Les États-Unis détenaient la plus grande part de marché en 2022.
Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics et VolitionRx Limited comptent parmi les principales sociétés opérant sur le marché nord-américain du cancer colorectal.
North America Colorectal Cancer Strategic Insights
Strategic insights for North America Colorectal Cancer involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
The regional scope of North America Colorectal Cancer refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - North America Colorectal Cancer Market
Abbott
Amgen Inc.
Bruker Corporation
Clinical Genomics Technologies Pty Ltd.
Epigenomics AG
F. Hoffmann-La Roche AG
Quest Diagnostics
VolitionRx Limited
Frequently Asked Questions
How big is the North America Colorectal Cancer Market?
The North America Colorectal Cancer Market is valued at US$ 8,559.27 Million in 2022, it is projected to reach US$ 11,198.11 Million by 2028.
What is the CAGR for North America Colorectal Cancer Market by (2022 - 2028)?
As per our report North America Colorectal Cancer Market, the market size is valued at US$ 8,559.27 Million in 2022, projecting it to reach US$ 11,198.11 Million by 2028. This translates to a CAGR of approximately 3.4% during the forecast period.
What segments are covered in this report?
The North America Colorectal Cancer Market report typically cover these key segments-
Modalité (type de diagnostic, type de thérapie, type d\'imagerie)
Utilisateur final (hôpitaux, laboratoires de diagnostic et de recherche)
What is the historic period, base year, and forecast period taken for North America Colorectal Cancer Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Colorectal Cancer Market report:
Historic Period : 2020-2021
Base Year : 2022
Forecast Period : 2023-2028
Who are the major players in North America Colorectal Cancer Market?
The North America Colorectal Cancer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Abbott
Amgen Inc.
Bruker Corporation
Clinical Genomics Technologies Pty Ltd.
Epigenomics AG
F. Hoffmann-La Roche AG
Quest Diagnostics
VolitionRx Limited
Who should buy this report?
The North America Colorectal Cancer Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the North America Colorectal Cancer Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For North America Colorectal Cancer Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines